Infective endocarditis: diagnosis, treatment and prevention An overview of the pathogenesis, diagnosis, treatment and prevention of infective endocarditis, as well as the role of the pharmacist in managing the infection.…
Discharge of bacteria from sewage into UK rivers risks antimicrobial resistance, experts warn The chief medical officer for England, and the chairs of Ofwat and the Environment Agency, have said water companies are not doing enough to prevent sewage and coliforms from escaping into UK rivers.…
Antibiotic use in older adults linked to inflammatory bowel disease, research suggests Patients aged 60 years and over who had received five or more courses of antibiotics in five years were 2.3 times more likely to develop inflammatory bowel disease.…
Pharmacies prevented from signing up for minor ailments service over AMR concerns NHS England has paused sign-ups for the extended care service in the Midlands while it carries out a review of community pharmacy services where antibiotics are supplied without a prescription.…
Pharmacist antibiotic use doubles after sore throat testing requirement is removed Data from the Welsh community pharmacy Sore Throat Test and Treat (STTT) service show that antibiotic prescribing increased from 27% to 63% during the COVID-19 pandemic.…
Clostridioides difficile infection: management A summary of the updates to National Institute for Health and Care Excellence guidance related to the management of Clostridioides difficile infection and the implications for pharmacy practice across primary and secondary care.…
Delaying antibiotics is safe and effective in respiratory tract infection, analysis concludes Researchers found no difference in symptom severity when comparing patients who received delayed antibiotics with those who received them immediately or not at all.…
First antimicrobial drugs purchased via new ‘subscription’ payment model The first antimicrobial drugs have been purchased via the UK’s new ‘subscription-type’ payment model.…
Azithromycin has no benefit for patients with severe COVID-19, RECOVERY trial data suggest The antibiotic azithromycin has no meaningful clinical benefit for patients who are hospitalised with severe COVID-19, a preliminary analysis of data from the Randomised Evaluation of COVID-19 Therapy trial has found.…
IV antibiotics no more effective than oral for eradicating infection in cystic fibrosis patients, study suggests Intravenous antibiotics are not superior to oral antibiotics for eradicating Pseudomonas aeruginosa in cystic fibrosis patients, according to a randomised controlled trial in Lancet Respiratory Medicine.…